Metabolism of Amyloid Proteins
- 28 September 2007
- book chapter
- other
- Published by Wiley
- Vol. 199, 104-118
- https://doi.org/10.1002/9780470514924.ch7
Abstract
Metabolic processing of amyloid precursor proteins is an important factor in the genesis of practically all forms of amyloidosis. Of the three major forms of systemic amyloidosis, reactive amyloid (amyloid A protein; AA) formation shows the most consistent role of partial proteolysis of serum amyloid A (SAA) to AA proteins which form fibrils. Immunoglobulin amyloidosis is also usually associated with C-terminal degradation of the fibril precursor light chain protein. Although it is commonly thought that transthyretin amyloidosis is associated with fibril formation from the tetrameric circulating plasma transthyretin, chemical analyses of transthyretin fibril deposits show significant fragmentation of the fibril protein constituents. In addition, it has been documented that proteolytic fragments are the fibril subunit proteins in gelsolin, cystatin C, Alzheimer's β-amyloid precursor protein and apolipoprotein AI (apoAI) amyloidoses. Notable exceptions to the role of proteolysis in amyloid fibril formation would appear to be the lysozyme and β2-microglobulin amyloidoses. Few studies have examined the metabolism of amyloid-forming proteins. Perhaps the best data are on apoAI, which show decreased plasma residence time for the amyloidogenic Gly26Arg apoAI (1.8 d vs. normal 4.5 d). Similarly, preliminary data show increased clearance of Val30Met transthyretin when compared with the wild-type protein (18 h vs. 26 h). Also, biosynthetically 35S-labelled SAA proteins reconstituted with HDL show increased plasma clearance of murine SAA2, the amyloid fibril subunit protein, when compared with murine SAA1. Few data are available on metabolism of amyloid immunoglobulin light chain proteins, but it has been shown that radiolabelled Bence–Jones proteins are cleared very rapidly from the circulation. A better understanding of the metabolism of precursor proteins in each of the amyloid deposition diseases will give insight into the mechanisms of fibril formation and pathogenesis of amyloidosis.Keywords
This publication has 36 references indexed in Scilit:
- Demonstration of a Circulating 65K Gelsolin Variant Specific for Familial Amyloidosis, Finnish TypeBiochemical and Biophysical Research Communications, 1993
- Use of an Anti‐Idiotypic Monoclonal Antibody in Studying Amyloidogenic Light Chains in Cells, Urine and Fibrils: Pathophysiology and Clinical ImplicationsScandinavian Journal of Immunology, 1992
- Studies on the synthesis and secretion of transthyretin by the human hepatoma cell line Hep G2FEBS Letters, 1991
- Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis.JCI Insight, 1990
- Relation of Neuronal APP-751/APP-695 mRNA Ratio and Neuritic Plaque Density in Alzheimer's DiseaseScience, 1990
- Expression of the Alzheimer amyloid precursor gene transcripts in the human brainNeuron, 1988
- Variant apolipoprotein AI as a major constituent of a human hereditary amyloidBiochemical and Biophysical Research Communications, 1988
- Amyloidogenesis. One serum amyloid A isotype is selectively removed from the circulation.The Journal of Experimental Medicine, 1986
- Amyloid Deposits and AmyloidosisNew England Journal of Medicine, 1980
- Amyloid Deposits and AmyloidosisNew England Journal of Medicine, 1980